Long-term survival in patients with metastatic melanoma who received ipilimumab in four phase II trials

被引：0
|
作者：
Lebbe, Celeste
Weber, Jeffrey S.
Maio, Michele
Neyns, Bart
Harmankaya, Kaan
Hamid, Omid
O'Day, Steven
Chin, Kevin M.
McDowell, Diane Opatt
Cykowski, Lori
McHenry, Brent
Wolchok, Jedd D.
机构：
[1] Hop St Louis, Paris, France
[2] Comprehens Melanoma Res Ctr, Moffitt Canc Ctr, Tampa, FL USA
[3] Univ Hosp Siena, Ist Toscano Tumori, Siena, Italy
[4] UZ Brussel, Brussels, Belgium
[5] Med Univ Vienna, Div Gen Dermatol, Dept Dermatol, Vienna, Austria
[6] Angeles Clin & Res Inst, Santa Monica, CA USA
[7] Beverly Hills Canc Ctr, Beverly Hills, CA USA
[8] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
[9] Bristol Myers Squibb Co, Lawrenceville, NJ USA
[10] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9053
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Long-term survival of patients (pts) with advanced melanoma treated with ipilimumab with or without dacarbazine
    Hersh, E.
    Weber, J.
    Powderly, J.
    Pavlik, A.
    Nichol, G.
    Yellin, M.
    Cranmer, L.
    Urba, W.
    O'Day, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [22] Long-Term Survival in Patients with Metastatic Melanoma Treated with DTIC or Temozolomide
    Kim, Christina
    Lee, Christopher W.
    Kovacic, Laurel
    Shah, Amil
    Klasa, Richard
    Savage, Kerry J.
    ONCOLOGIST, 2010, 15 (07): : 765 - 771
  • [23] Durable, long-term survival in previously treated patients with advanced melanoma (MEL) who received nivolumab (NIVO) monotherapy in a phase I trial
    Hodi, F. Stephen
    Kluger, Harriet
    Sznol, Mario
    Carvajal, Richard
    Lawrence, Donald
    Atkins, Michael
    Powderly, John
    Sharfman, William
    Puzanov, Igor
    Smith, David
    Leming, Philip
    Lipson, Evan
    Taube, Janis
    Anders, Robert
    Horak, Christine
    Jiang, Joel
    McDermott, David
    Sosman, Jeffrey
    Brahmer, Julie
    Pardoll, Drew
    Topalian, Suzanne
    CANCER RESEARCH, 2016, 76
  • [24] Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
    Hodi, F. Stephen
    O'Day, Steven J.
    McDermott, David F.
    Weber, Robert W.
    Sosman, Jeffrey A.
    Haanen, John B.
    Gonzalez, Rene
    Robert, Caroline
    Schadendorf, Dirk
    Hassel, Jessica C.
    Akerley, Wallace
    van den Eertwegh, Alfons J. M.
    Lutzky, Jose
    Lorigan, Paul
    Vaubel, Julia M.
    Linette, Gerald P.
    Hogg, David
    Ottensmeier, Christian H.
    Lebbe, Celeste
    Peschel, Christian
    Quirt, Ian
    Clark, Joseph I.
    Wolchok, Jedd D.
    Weber, Jeffrey S.
    Tian, Jason
    Yellin, Michael J.
    Nichol, Geoffrey M.
    Hoos, Axel
    Urba, Walter J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08): : 711 - 723
  • [25] Ipilimumab improves survival in metastatic melanoma patients
    Hodi, F. S.
    O'Day, S. J.
    McDermott, D. F.
    IMMUNOTHERAPY, 2011, 3 (08) : 928 - 929
  • [26] PHASE II STUDY OF IPILIMUMAB PLUS TEMOZOLOMIDE IN PATIENTS WITH METASTATIC MELANOMA
    Patel, S.
    Bassett, R.
    Hwu, W.
    Kim, K.
    Papadopoulos, N.
    Hwu, P.
    Bedikian, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 366 - 367
  • [27] A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma
    Patel, Sapna P.
    Kim, Dae Won
    Bassett, Roland L.
    Cain, Suzanne
    Washington, Edwina
    Hwu, Wen-Jen
    Kim, Kevin B.
    Papadopoulos, Nicholas E.
    Homsi, Jade
    Hwu, Patrick
    Bedikian, Agop Y.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (10) : 1359 - 1366
  • [28] A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma
    Sapna P. Patel
    Dae Won Kim
    Roland L. Bassett
    Suzanne Cain
    Edwina Washington
    Wen-Jen Hwu
    Kevin B. Kim
    Nicholas E. Papadopoulos
    Jade Homsi
    Patrick Hwu
    Agop Y. Bedikian
    Cancer Immunology, Immunotherapy, 2017, 66 : 1359 - 1366
  • [29] Survival and long-term toxicities of biochemotherapy for metastatic melanoma
    Minor, D. R.
    Miller, J.
    Kashani-Sabet, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [30] Long-term Survival after Metastatic Childhood Melanoma
    Larsen, Anne Kristine
    Jensen, Mette Bybjerg
    Krag, Christen
    PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN, 2014, 2 (06)
12345